Christine Monteleon

Christine Monteleon is a Senior Scientist at Turn Biotechnologies since August 2022, with a background in cellular and molecular biology. Prior experience includes serving as a Scientist at Notable, where the focus was on developing a high throughput flow cytometry platform for multiple myeloma treatments. Christine also worked as a Molecular Engineer at Emerald Therapeutics, contributing to antiviral therapy research using nucleic acid nanotechnology. Earlier roles include a postdoctoral fellowship at the University of Pennsylvania, investigating epithelial homeostasis and cancer progression, and graduate research at the University of Notre Dame, focused on epithelial architecture and matrix remodeling. Christine's academic credentials include a Ph.D. in Cellular and Molecular Biology from the University of Notre Dame and a B.S. in Biological Sciences from the University of Michigan.